Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate in AMD Patients Not Meeting Standard Care Criteria
NCT00211484Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- May 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in age-related macular degeneration (AMD), sponsored by Manhattan Eye, Ear and Throat Hospital. Started May 2003; status: completed.
02
Drugs
anecortave
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00211484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211484.